We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVRA icon
8201
CALL
Savara
SVRA
$1.11B
$76K ﹤0.01%
10,000
-8,500
-46% -$76.5K
LEAF
8202
CALL
DELISTED
Leaf Group Ltd.
LEAF
$76K ﹤0.01%
11,100
-6,800
-38% -$58.4K
FOMX
8203
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$76K ﹤0.01%
21,300
-36,600
-63% -$159K
UPL
8204
PUT
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$76K ﹤0.01%
99,700
+2,600
+3% +$3.29K
DBRG icon
8205
CALL
DigitalBridge
DBRG
$2.94B
$75K ﹤0.01%
4,025
+750
+23% +$17.2K
GNE icon
8206
Genie Energy
GNE
$383M
$75K ﹤0.01%
12,445
-835
-6% -$5.24K
GPL
8207
DELISTED
Great Panther Mining Limited
GPL
$75K ﹤0.01%
10,531
+3,459
+49% +$22.8K
SREV
8208
DELISTED
ServiceSource International, Inc.
SREV
$75K ﹤0.01%
69,820
-140,593
-67% -$221K
MRT
8209
DELISTED
MedEquities Realty Trust, Inc.
MRT
$75K ﹤0.01%
10,919
-25,881
-70% -$203K
BRFS
8210
CALL
DELISTED
BRF SA
BRFS
$74K ﹤0.01%
+13,000
New +$73.4K
NAK
8211
PUT
Northern Dynasty Minerals
NAK
$908M
$74K ﹤0.01%
130,000
+31,500
+32% +$18.9K
OCUL icon
8212
PUT
Ocular Therapeutix
OCUL
$2.2B
$74K ﹤0.01%
18,600
+8,200
+79% +$45.2K
TWI icon
8213
PUT
Titan International
TWI
$445M
$74K ﹤0.01%
+15,900
New +$103K
TNAV
8214
DELISTED
Telenav Inc.
TNAV
$74K ﹤0.01%
18,280
-10,425
-36% -$44.9K
PGNX
8215
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$74K ﹤0.01%
17,600
-28,600
-62% -$146K
ACET
8216
DELISTED
Aceto Corp
ACET
$74K ﹤0.01%
88,454
+76,537
+642% +$137K
FENG
8217
Phoenix New Media
FENG
$18.1M
$73K ﹤0.01%
3,813
+55
+1% +$1.13K
NGNE icon
8218
PUT
Neurogene
NGNE
$723M
$73K ﹤0.01%
1,685
-5,095
-75% -$248K
RRD
8219
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$73K ﹤0.01%
18,400
+3,700
+25% +$19.2K
UAN icon
8220
CVR Partners
UAN
$1.31B
$72K ﹤0.01%
+2,124
New +$80.3K
NAGE
8221
Niagen Bioscience
NAGE
$239M
$72K ﹤0.01%
21,050
-23,286
-53% -$80.9K
ANH
8222
PUT
DELISTED
Anworth Mortgage Asset Corporation
ANH
$72K ﹤0.01%
17,900
-7,200
-29% -$31.6K
JMEI
8223
CALL
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$72K ﹤0.01%
3,930
-1,700
-30% -$34.7K
AFMD
8224
PUT
DELISTED
Affimed
AFMD
$71K ﹤0.01%
2,290
-1,430
-38% -$53.2K
GALT icon
8225
Galectin Therapeutics
GALT
$347M
$71K ﹤0.01%
+20,727
New +$99K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.